Aspirin's Potential in Treating Anaplastic Thyroid Cancer
Author Information
Author(s): Enke Baldini, Silvia Cardarelli, Eleonora Lori, Elena Bonati, Federica Gagliardi, Daniele Pironi, Poupak Fallahi, Alessandro Antonelli, Vito D’Andrea, Salvatore Ulisse, Salvatore Sorrenti
Primary Institution: Sapienza University of Rome
Hypothesis
Can aspirin inhibit the proliferation and survival of anaplastic thyroid cancer cells?
Conclusion
Aspirin treatment significantly inhibits the growth and survival of anaplastic thyroid cancer cells in vitro.
Supporting Evidence
- Aspirin significantly inhibited the proliferation of all ATC cell lines with IC50 values between 2.0 and 4.3 mM.
- ASA treatment led to increased apoptosis in all treated ATC cell lines.
- ASA reduced cell migration and invasion in two of the three ATC cell lines.
- ASA impaired the ability of ATC cells to form colonies in soft agar.
Takeaway
Aspirin might help fight a very aggressive type of thyroid cancer by stopping the cancer cells from growing and spreading.
Methodology
The study evaluated the effects of aspirin on three anaplastic thyroid cancer cell lines in vitro, measuring proliferation, migration, invasion, and apoptosis.
Potential Biases
Potential biases may arise from the in vitro nature of the study and the specific cell lines used.
Limitations
The study is preclinical and results may not directly translate to clinical outcomes in patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website